Skip to content

Sleep-related Breathing Disorders in Cardiological Outpatients

Sleep-related Breathing Disorders in Cardiological Outpatients From a German University Clinic - Prevalence, Classification, Diagnostic Accuracy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02693925
Acronym
SRBD-Cardio
Enrollment
90
Registered
2016-02-29
Start date
2014-12-16
Completion date
2018-09-28
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndromes

Brief summary

The purpose of this study is to determine the prevalence of sleep-related breathing disorders (SRBD) in clinically stable cardiologic outpatients of a German university clinic by means of polygraphy. Furthermore, the practicability of the underlying diagnostic process in clinical application is assessed as well as the sensitivity and specificity of polygraphy as compared to the reference standard of polysomnography. Another aim is to determine the individual cardiovascular risk profile by pulse wave analysis and risk classification according to European Society of Hypertension (ESH) and European Society of Cardiology (ESC), ESH/ESC risk.

Interventions

None listed

Sponsors

University Clinic Cologne
CollaboratorUNKNOWN
Wissenschaftliches Institut Bethanien e.V
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Present chronic cardiovascular disease (incl. but not limited to: ischemic heart disease, arterial hypertension, heart failure, atrial fibrillation) * Current clinically stable state (incl. patients after a cardiovascular-related, emergency hospital admission and subsequent recompensation towards the end of their hospital stay

Exclusion criteria

* Age \<18 years * Acute life-threatening disease (incl. but not limited to:instable angina pectoris, acute bronchial asthma, heart failure New York Heart Association (NYHA) stage IV, myocardial infarction, exacerbated chronic obstructive pulmonary disease (COPD), Malignant disease requiring treatment) * Pregnancy and/or lactation * Any medical, psychological or other condition impairing the patient's ability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of sleep-related breathing disordersOnce within two days of inclusionPrevalence of sleep-related breathing disorders as measured by ambulatory polygraphy and defined as an respiratory disturbance index of \>=15/h

Secondary

MeasureTime frameDescription
Number of patients includedthrough study completion, an average of 21 monthsTotal number of patients included in the study after overall study conclusion
Number of patients with actually performed polygraphythrough study completion, an average of 21 monthsTotal number of patients in whom ambulatory polygraphy was actually performed, after overall study conclusion
Number of patients with assessable polygraphythrough study completion, an average of 21 monthsTotal number of patients in whom ambulatory polygraphy was assessable, after overall study conclusion
Number of patients with actually performed polysomnographythrough study completion, an average of 21 monthsTotal number of patients in whom stationary polysomnography was actually performed, after overall study conclusion
Number of patients with assessable polysomnographythrough study completion, an average of 21 monthsTotal number of patients in whom stationary polysomnography was assessable, after overall study conclusion

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026